If you are currently using IE 11 or earlier, we recommend you update to the new Microsoft Edge or visit our site on another supported browser.
A personalized healthcare company focused mainly on genetic testing, Genomind uses the Article Galaxy platform to streamline its R&D processes, while ensuring top value for its customers.
Headquarters: Pennsylvania, USA
Headcount: 200 employees
Genomind is a personalized medicine platform that provides genetic testing for both clinicians and patients, including tests for psychiatric conditions and optimal patient treatment options.
Genomind leverages Article Galaxy for easy scientific literature access, 24/7. Key features include:
In today’s fast-paced and competitive industry landscape, Genomind was looking for new ways to deliver top value to its customers, while streamlining its R&D processes.
Its improvement effort centered on three objectives: improving content awareness, facilitating copyright compliance, and eliminating wasteful spending due to duplicate article orders.
In selecting the Article Galaxy research platform, Genomind successfully addressed the top three challenges it sought to overcome:
Using the solution’s table-of-contents (TOC) notification feature, team members are alerted whenever relevant content is published.
Article Galaxy provides a central location for the company’s entire collection of previously-acquired, copyright-cleared journal PDFs.
When placing an order, team members receive a duplicate order alert if they already own the article, eliminating costs of duplicate purchases.
Vice President of Medical Affairs